1. The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series. (10th January 2021) Authors: McMillan, Annabel; O'Neill, Aideen T.; Townsend, William; Lambert, Jonathan.; Virchis, Andres; Shah, Raakhee; Menezes, Leon; Humphries, Paul; Von Both, Kirsten; Grandage, Victoria; Carpenter, Ben; Hough, Rachael; Ardeshna, Kirit M.; Daw, Stephen Journal: British journal of haematology Issue: Volume 192:Number 3(2021) Page Start: e84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗